Physician profile
Lenora Brown
NPI 1023110525
$1,759.51
in general payments reported to CMS, 2019-2025
21 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $207 · 2022: $297 · 2023: $842 · 2024: $209 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $813 · Education: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $813.44 |
| Education | $441.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $519.50 | 2021-2024 | Enhertu |
| Seagen INC. | $408.58 | 2023-2025 | Padcev |
| Amgen INC. | $180.72 | 2021-2023 | Blincyto, Lumakras, Kyprolis |
| Astellas Pharma US INC | $111.00 | 2022-2024 | |
| Ipsen Biopharmaceuticals, INC | $77.99 | 2025 | |
| Abbvie INC. | $52.53 | 2023-2025 | |
| Genmab U.S., INC. | $50.01 | 2023 | Epkinly |
| Emd Serono, INC. | $49.71 | 2023 | Bavencio |
| Janssen Biotech, INC. | $46.39 | 2021 | |
| Novartis Pharmaceuticals Corporation | $37.01 | 2022 | |
| Lilly USA, LLC | $28.95 | 2021 | |
| Coherus Oncology, INC. | $28.52 | 2023 | |
| Adc Therapeutics America, INC. | $22.75 | 2023 | |
| Genzyme Corporation | $21.88 | 2023 | |
| Pfizer INC. | $21.39 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $20.04 | 2025 | Keytruda |
| Incyte Corporation | $19.94 | 2023 | Monjuvi |
| Astrazeneca Pharmaceuticals Lp | $19.62 | 2023 | |
| Stemline Therapeutics INC. | $15.32 | 2021 | |
| Alexion Pharmaceuticals, INC. | $14.07 | 2021 | |
| Sobi, INC | $13.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lenora Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.